Navigation Links
Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals
Date:1/7/2009

SEATTLE, Jan. 8 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that they received $7.5 million pursuant to the joint venture transaction with Spectrum Pharmaceuticals, Inc. to commercialize and develop Zevalin(R) in the United States. In December, the Company received the initial $7.5 million payment in connection with the closing of such transaction. The Company may earn up to an additional $15 million in product sales milestone payments upon achievement of certain revenue targets.

Zevalin, a radioimmunotherapeutic, was exclusively marketed by CTI in the United States since December, 2007 and is now marketed jointly by CTI and Spectrum through RIT Oncology, LLC ("RIT") for the treatment of patients with relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL), including patients who have rituximab-refractory follicular NHL. CTI holds a sale option exercisable from January 15, 2009 through July 15, 2009 in its sole discretion to sell its 50% membership interest in RIT to Spectrum for $18 million. The FDA has accepted for filing and review, and has granted priority review status for a supplemental Biologics License Application (sBLA) for use of Zevalin as consolidation therapy in patients with follicular B-cell non-Hodgkin's lymphoma who achieve a response to first-line therapy and expects a decision regarding the sBLA in early April, 2009.

About Zevalin(R)

Zevalin(R) (Ibritumomab Tiuxetan) is a form of cancer therapy called radioimmunotherapy and is indicated as part of the Zevalin therapeutic regimen for treatment of relapsed or refractory, lowgrade or follicular B-cell non-Hodgkin's lymphoma, including patients with rituximab refractory follicular NHL. Zevalin is also indicated, under accelerated approval, for the treatment of relapsed or refractory, rituximab-naive, low-grade and follicular NHL based on studies using a sur
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014 Hoping to attract new customers ... trust , NutriGold is ready to ship out free ... make taking advantage of this offer fast and easy: ... and Development at NutriGold, "We know that every time customers ... their most precious asset: their own health or the health ...
(Date:7/31/2014)... TN (PRWEB) July 31, 2014 In many ... are required for proper storage of necessary life saving drugs. ... staff. Unfortunately there is still a high number of ambulances ... an EMT who steals the narcotics and even replaces the ... relief receives none. As seen in the case in Baraboo, ...
(Date:7/31/2014)... Niche Profit Classroom, a method and guide ... to provide a blueprint for anyone who is interested in ... prompting an investigative review. , Learn more about ... about the success of the information in this course is ... have stayed effective even through all of the major search ...
(Date:7/31/2014)... United Theological Seminary is pleased to welcome ... and Peter J. Bellini. Both began their teaching duties ... a Director of Non-Degree Programs, Mark Abbott, who begins ... Donne, Assistant Professor of New Testament, received a Ph.D. ... Second Temple Judaism, and Greek courses. His research interests ...
(Date:7/31/2014)... Angeles, CA (PRWEB) July 31, 2014 US ... his practice will now be known as Parsa Mohebi Hair ... has helped hundreds of patients in Southern California and around ... Los Angeles, Beverly Hills and Orange County. These patients achieved ... including many surgical techniques that were perfected by Dr. Mohebi. ...
Breaking Medicine News(10 mins):Health News:NutriGold Launches Product Samples Page for its Supplements 2Health News:NutriGold Launches Product Samples Page for its Supplements 3Health News:New MedixSafe Alert - Ambulances Must Have A Medical Safe, Narcotics Cabinet, or Drug Locker 2Health News:Niche Profit Classroom: Review Exposes Adam Short’s Guide to Building Niche Websites 2Health News:Growing Seminary Welcomes New Faculty 2Health News:US Hair Restoration Becomes Parsa Mohebi Hair Restoration 2
... Today the International and American Associations for Dental Research ... remains the number one journal of 64 journal published in ... new 2009 Five-Year Scientific Impact Factor (SIF) rankings, published by ... the JDR,s Five-Year SIF increased from 3.966 to 4.195. ...
... , ... open to the public, Andy Thomas job seminars teach participants unique personal marketing strategies ... Minutes to a Better Career”; Career counselor Thomas is a former talk show host ... 60 unemployed in attendance, and a drawing will be held for Thomas providing free ...
... DocGreet.com is ... their time and streamline their patient communication, that the company has announced a money back ... ... sure that the services available to Doctors, Physicians and Health Care Providers will monetize their ...
... ... of the Enterprise Architecture Professional Practice Guide and a brochure on Enterprise Architecture as a ... (PRWEB) June ... ,These abstracts provide the enterprise architect,s contract with the public they serve and consist of ...
... colonoscopy is effective and cost-effective when targeted to ... Gastroenterology , the official journal of the ... surveillance colonoscopy could be excessively costly or even ... and utilized practice that has the potential to ...
... Institute (NHLBI), part of the National Institutes of Health, is ... efficacy of red blood cell transfusions vary depending on how ... supports the first large, multi-center, randomized clinical trial to compare ... blood cells that have been stored for shorter or longer ...
Cached Medicine News:Health News:JDR increases its 5-Year SIF and remains number one dental journal of 64 in its category 2Health News:Columbia Extreme Job Makeover Slated for June 26 2Health News:Columbia Extreme Job Makeover Slated for June 26 3Health News:DocGreet Guarantees More Time and Money to Doctors and Health Care Providers 2Health News:Enterprise Architecture -- Breaking Away From The Pack 2Health News:Surveillance colonoscopy should be targeted to high-risk patients 2Health News:NHLBI funds research to improve safety of red blood cell transfusions 2Health News:NHLBI funds research to improve safety of red blood cell transfusions 3Health News:NHLBI funds research to improve safety of red blood cell transfusions 4Health News:NHLBI funds research to improve safety of red blood cell transfusions 5Health News:NHLBI funds research to improve safety of red blood cell transfusions 6Health News:NHLBI funds research to improve safety of red blood cell transfusions 7
(Date:7/31/2014)... 2014  Decision Resources Group,s experts are ... the Affordable Care Act (ACA), which has ... therapies. The ACA altered how Managed Care ... and expanded access via government-supported programs. Dynamic ... marketplaces set up by states or the ...
(Date:7/31/2014)... July 31, 2014 Touro University California,s College ... selected as the recipient of a $150,000 grant by ... the University to increase research and classroom space on ... technology for the study of health sciences, and will ... needs and interests of our students," said Shelley ...
(Date:7/31/2014)... Iowa , July 31, 2014 For ... California , Art,s-Way Scientific has earned ... With competition in over 30 categories, MBI,s ... for MBI members, which include building manufacturers, dealers, and ... is an excellent example the capability of our team," ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Touro University California Garners Grant From Long Foundation 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4
... WuXi PharmaTech (Cayman) Inc. (NYSE: WX ... serving the pharmaceutical, biotechnology, and medical device industries, ... today announced its financial results for third-quarter 2010. ... (Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO ) Third-Quarter ...
... LLC (US HIFU), a world leader in minimally invasive ... the Sonablate ® 500 (Sonablate) and Sonatherm ® ... 18 clinical trial sites involved in the recurrent prostate ... prostate cancer trial, or STAR trial, is a multi-center ...
Cached Medicine Technology:WuXi PharmaTech Announces Third-Quarter 2010 Results 2WuXi PharmaTech Announces Third-Quarter 2010 Results 3WuXi PharmaTech Announces Third-Quarter 2010 Results 4WuXi PharmaTech Announces Third-Quarter 2010 Results 5WuXi PharmaTech Announces Third-Quarter 2010 Results 6WuXi PharmaTech Announces Third-Quarter 2010 Results 7WuXi PharmaTech Announces Third-Quarter 2010 Results 8WuXi PharmaTech Announces Third-Quarter 2010 Results 9WuXi PharmaTech Announces Third-Quarter 2010 Results 10WuXi PharmaTech Announces Third-Quarter 2010 Results 11WuXi PharmaTech Announces Third-Quarter 2010 Results 12WuXi PharmaTech Announces Third-Quarter 2010 Results 13WuXi PharmaTech Announces Third-Quarter 2010 Results 14WuXi PharmaTech Announces Third-Quarter 2010 Results 15WuXi PharmaTech Announces Third-Quarter 2010 Results 16US HIFU Announces That 18 Recurrent Prostate Cancer Clinical Trial Sites Are Open For Enrollment 2US HIFU Announces That 18 Recurrent Prostate Cancer Clinical Trial Sites Are Open For Enrollment 3
... Bottled Water, The Simplicity personal water system ... currently use bottled water. In addition to ... store bottled water, your laboratory applications may ... be absorbed from containers and cause water ...
... to 12 L/min of Type I ultrapure ... The Super-Q Plus System is designed to ... has been pretreated by reverse osmosis, distillation ... ultrapure water quality which exceeds Type I ...
... System Produces Type I Water Directly from Tap, ... for scientists who need 5 to 15 L ... have easy access to acceptable quality pretreated water. ... L/min of ultrapure (Type I) water on demand, ...
TOPLOAD 3200/0.01G, BL3200H. Touch-key external calibration only. Requires calibration weights (either 2000g or 3000g). 120/240V A/C adapter, Lock-down Ring, In-use Protective Cover....
Medicine Products: